Biotech drug market steadily expands
نویسندگان
چکیده
منابع مشابه
Market Sensitivity and Methods to Ensure Tolerance of Biotech and Non-biotech Alfalfa Production Systems
Roundup-Ready® alfalfa was released in June of 2005, the first trait to be commercialized in alfalfa (Medicago sativa L.) using biotechnology. Traditional alfalfa varieties will likely be grown in close proximity to these new biotech varieties. While most users will probably not be sensitive to the presence of these varieties, other markets (particularly export and organic) will request hay tha...
متن کاملChina's new drug R&D is steadily advancing.
China appears to consistently lag behind developed countries like the US, Japan, and the nations of Europe in the development of pharmaceuticals, putting China in an embarrassing situation. In fact, China is still dependent on foreign imports for most highly effective cures to major diseases such as cancer, diabetes, hepatitis, and neurodegenerative disease. There is no denying the fact that go...
متن کاملTargeting Biotech Drugs Nanosized Lipid Particles versus Drug Nanocrystals
Nanotechnology and, in particular, the development of nanosized delivery systems for biotech drugs (namely peptides, proteins and oligonucleotides), is a multidisciplinary field undergoing exponential development in the latest years [1-3]. The rate of these developments has been dictated in parallel by the progress of biotechnology. Biotechnological techniques have expanded the variety of thera...
متن کاملAppearance of Steadily
An interocular matching technique was used to investigate the variation of chromaticity and brightness following steady viewing of a chromatic test light (identical adapting and testing color). Adaptation times were of sufhcient duration to ensure stable matches. Following chromatic adaptation we found changes in hue, saturation and brightness. The spectral colors appeared desaturated. The hue ...
متن کاملMarket entry and exit by biotech and device companies funded by venture capital.
Start-up companies in the biotechnology and medical device sectors are important sources of health care innovation. This paper describes the role of venture capital in supporting these companies and charts the growth in venture capital financial support. The paper then uses longitudinal data to describe market entry and exit by these companies. Similar factors are associated with entry and exit...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nature Biotechnology
سال: 2005
ISSN: 1087-0156,1546-1696
DOI: 10.1038/nbt1205-1466